The ability of the CXCR4 antagonist to reduce pneumonia in our CXCR2 LOF mice is likely related to its ability to mobilize neutrophils and facilitate their emigration into infected tissues rather than directly influencing neutrophil effector functions. The gene discussed is CXCR4; the disease is pneumonia.